Singular Health Group Ltd
Singular Health Group Ltd (SHG.AX) Stock Overview
Explore Singular Health Group Ltd’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
104.1M
P/E Ratio
-37.32
EPS (TTM)
$-0.02
ROE
-0.80%
SHG.AX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Singular Health Group Ltd (SHG.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.46.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -37.32 and a market capitalization of 104.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Singular Health Group Ltd, a medical technology company, develops and commercializes volumetric rendering platform (VRP) for the 3D and virtual reality (VR) visualization of anatomy using standard radiological imagery. It offers 3Dicom Viewer, a cross-platform application that allows its users to interact with standard 2D medical images; 3DicomVSP, an end-to-surgical planning platform; Health Academy, a scalable multi-lingual platform that provides templated curriculum aligned lessons; and GeoVR, a cloud platform for use in the mineral resources sector. The company was founded in 2017 and is headquartered in Subiaco, Australia.
Denning Chong
8
26 Railway Road, Bibra Lake, WA
2021